Related Experiment Video
Updated: Feb 12, 2026
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.8K
Lipids, inflammation, and chronic kidney disease: a SHARP perspective.
David D Waters1, Liffert Vogt2
1Division of Cardiology, Zuckerberg San Francisco General Hospital, San Francisco, California, USA.
Kidney International
|March 25, 2018
Summary
Inflammation, indicated by C-reactive protein, is linked to chronic kidney disease progression and nonvascular events. While statin therapy reduced cardiovascular events, it did not rule out inflammation
Area of Science:
- Nephrology
- Cardiology
- Inflammation research
Background:
- Inflammation is increasingly recognized as a key factor in chronic kidney disease (CKD) development and progression.
- Elevated C-reactive protein (CRP) and low-density lipoprotein cholesterol (LDL-C) are associated with adverse outcomes in CKD patients.
- The Study of Heart and Renal Protection (SHARP) trial investigated cardiovascular events in CKD patients.
Purpose of the Study:
- To examine the association between baseline inflammation markers and cardiovascular/nonvascular events in CKD patients.
- To evaluate the effect of simvastatin/ezetimibe on cardiovascular events in relation to baseline CRP levels.
Main Methods:
- Analysis of baseline CRP and LDL-C levels in relation to event risk within the SHARP trial cohort.
- Assessment of cardiovascular event reduction by simvastatin/ezetimibe, stratified by baseline CRP levels.
Main Results:
- Higher baseline CRP and LDL-C levels were independently associated with increased cardiovascular event risk.
- Higher baseline CRP levels were also linked to a greater risk of nonvascular events.
- Simvastatin/ezetimibe effectively reduced cardiovascular events, irrespective of baseline CRP levels.
Conclusions:
- While simvastatin/ezetimibe benefits cardiovascular health in CKD patients, the role of inflammation as a causal factor requires further investigation.
- Inflammation remains a critical area of study for understanding and managing cardiovascular disease in the context of chronic kidney disease.
More Related Videos
Related Concept Videos
01:25Chronic Kidney Disease I: Introduction
766
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
766
01:24Chronic Kidney Disease II: Clinical Manifestations
683
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
683
01:28Chronic Kidney Disease III: Interprofessional Care
485
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
485
01:18Chronic Kidney Disease IV: Nursing Management
413
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
413
01:38Inflammation
62.4K
Overview
62.4K
01:24Chronic Obstructive Pulmonary Disease
2.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K